COVID‐19 associated EBV reactivation and effects of ganciclovir treatment
Mei Meng(Shanghai Ninth People's Hospital), Dechang Chen(Ruijin Hospital), Djillali Annane(Hôpital Raymond-Poincaré), Zhixiong Wu(Fudan University), Yunfeng Deng(Shandong Chest Hospital), Ranran Li(Linyi People's Hospital), Sheng Zhang(Shanghai East Hospital), Xuan Dong(The Ohio State University), Wenzhe Li(Shantou University), Wenqing Sun(Hsin Sheng College of Medical Care and Management)
Cited by 59
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k